What Intel Stock Was Telling You About The Coming AI-CPU Revival
Behind the chipmaker’s soaring share price was an overlooked story: the quiet, powerful resurgence of its oldest and most dominant product.
Heading into mid-2025, you could be forgiven for thinking Intel (INTC) was a value trap on its way to becoming a museum piece. As of its fiscal Q1 2025 results, the company’s trailing-twelve-month revenue was down 4.0% year over year, and it was carrying a deeply negative net margin of -36%. The numbers were grim enough to fuel entire narratives about the margin squeeze threatening Intel stock. The options market was snoozing, with implied volatility sitting in the placid 35th percentile of its annual range just weeks before the run began.
By all accounts, this was not a stock coiled for a 369% surge.
What Was The Market Missing?
- What Owning Intel Stock Means In A Market Crash
- S&P 500 Movers | Winners: CTSH, OXY, CBOE | Losers: INTC, TER, GNRC
- Intel’s $500 Billion Question: Where Are Foundry Proof Points?
- What An INTC Pullback Costs Your ETFs
- The Margin Squeeze Threatening Intel Stock
- The Real Price Of Intel Stock Is Three Years Away
Part of the story was a classic misdirection. All eyes were on Intel’s efforts to build a dedicated AI accelerator chip, Gaudi, to compete with the industry titans. And on that front, the news was not good. In late 2024, management admitted the uptake for Gaudi was “slower than we anticipated” and that it would miss its revenue target. By early 2025, the company announced it was scrapping the next-generation version, an internal project, as a commercial product. For anyone watching Intel’s direct assault on the AI training market, the story looked like a failure.
But this narrative overlooked the company’s core strength.
What Was Management Saying About Its Core CPU Business?
While the Gaudi narrative soured, a different, more powerful one was building in the background, often on the very same earnings calls. Management began to quietly but persistently talk about the evolving nature of AI. The conversation, they argued, was shifting from just training models to actually using them for inference, a workload where the classic server CPU, the Xeon, played a central role.
As far back as October 2024, the CEO stated that this solidified Intel’s position as the ‘head node of choice in AI servers,’ noting that as the industry moved toward inference, it would lean on workloads that are ‘much more CPU-centric’. By January 2025, his successor was reinforcing the company’s “leading position as the host CPU for AI servers” and the “significant opportunity for CPU-based inference.” The thesis was clear: the next wave of AI would create massive demand for CPUs alongside GPUs.
When Did That Story Start Showing Up In The Financials?
A good narrative is one thing; numbers are another. The final clue arrived in April 2025, with the company’s fiscal Q1 results. The report itself was mixed, but the details were telling. The CFO had landed at the high end of their guidance, explicitly “driven by better-than-expected Xeon sales.”
And the reason for that strength? It was, he said, “driven by hyperscaler demand for host CPUs for AI servers.” The quiet narrative had finally hit the income statement. DCAI revenue, the segment housing those chips, came in above expectations. It was the first concrete sign that the growing role of the CPU in the AI era was a tangible, revenue-generating reality.
The tell wasn’t in a flashy new product, but in the market rediscovering just how essential Intel’s oldest franchise was to the newest trend in technology.

And if it is exposure to semiconductor as a whole you want, rather than hunting the next single name to surge, a semiconductor ETF like SOXX covers that single sector.
Catching The Move Is Not The Same As Keeping It
Spotting a setup before it runs is a real edge – but a name you are excited about has a way of becoming an oversized part of your portfolio, and the same volatility that powers a surge can reverse it. Concentration turns that reversal into real damage, and selling to trim it triggers a tax bill. There is a way to lock in the gains and diversify without the tax hit.